METHODS: Using high-throughput DNA sequencing and Sanger sequencing, we detected variants in a female with clinically suspected PS. A minigene splicing assay was performed to assess the effect of LAMB2 intron 20 c.2885-9C>A on RNA splicing. We also performed the immunohistochemical analysis of laminin beta-2 in kidney tissues.
RESULTS: Two novel LAMB2 heteroallelic variants were found: a paternally inherited variant c.2885-9C>A in intron 20 and a maternally inherited variant c. 3658C>T (p. (Gln1220Ter)). In vitro minigene assay showed that the variant c.2885-9C>A caused erroneous integration of a 7 bp sequence into intron 20. Immunohistochemical analysis revealed the absence of glomerular expression of laminin beta-2, the protein encoded by LAMB2.
CONCLUSIONS: We demonstrated the impact of a novel LAMB2 intronic variant on RNA splicing using the minigene assay firstly. Our results extend the mutational spectrum of LAMB2.
方法:使用高通量DNA测序和Sanger测序,我们在一名临床怀疑PS的女性中检测到变异。进行小基因剪接测定以评估LAMB2内含子20c.2885-9C>A对RNA剪接的影响。我们还对肾组织中的层粘连蛋白β-2进行了免疫组织化学分析。
结果:发现了两个新的LAMB2异等位基因变体:内含子20中的父系遗传变体c.2885-9C>A和母系遗传变体c。3658C>T(p。(Gln1220Ter)。体外小基因测定显示变体c.2885-9C>A导致7bp序列错误整合到内含子20中。免疫组织化学分析显示缺乏LAMB2编码的层粘连蛋白β-2的肾小球表达。
结论:我们首先使用小基因测定证明了新型LAMB2内含子变体对RNA剪接的影响。我们的结果扩展了LAMB2的突变谱。